- Home
- NERV vs CMBM Comparison
NERV vs CMBM Comparison
Compare NERV & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- CMBM
- Stock Information
- Founded
- NERV 2007
- CMBM 2011
- Country
- NERV United States
- CMBM United States
- Employees
- NERV N/A
- CMBM N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- NERV Health Care
- CMBM Technology
- Exchange
- NERV Nasdaq
- CMBM Nasdaq
- Market Cap
- NERV 12.4M
- CMBM 12.1M
- IPO Year
- NERV 2014
- CMBM 2019
- Fundamental
- Price
- NERV $1.57
- CMBM $0.51
- Analyst Decision
- NERV Hold
- CMBM Strong Buy
- Analyst Count
- NERV 1
- CMBM 2
- Target Price
- NERV $5.00
- CMBM $5.50
- AVG Volume (30 Days)
- NERV 5.9K
- CMBM 107.7K
- Earning Date
- NERV 05-13-2025
- CMBM 05-23-2025
- Dividend Yield
- NERV N/A
- CMBM N/A
- EPS Growth
- NERV N/A
- CMBM N/A
- EPS
- NERV 0.82
- CMBM N/A
- Revenue
- NERV N/A
- CMBM $172,215,000.00
- Revenue This Year
- NERV N/A
- CMBM N/A
- Revenue Next Year
- NERV N/A
- CMBM $17.64
- P/E Ratio
- NERV $1.95
- CMBM N/A
- Revenue Growth
- NERV N/A
- CMBM N/A
- 52 Week Low
- NERV $1.15
- CMBM $0.23
- 52 Week High
- NERV $3.69
- CMBM $4.16
- Technical
- Relative Strength Index (RSI)
- NERV 40.93
- CMBM 56.81
- Support Level
- NERV $1.58
- CMBM $0.42
- Resistance Level
- NERV $1.74
- CMBM $0.47
- Average True Range (ATR)
- NERV 0.06
- CMBM 0.04
- MACD
- NERV -0.01
- CMBM 0.02
- Stochastic Oscillator
- NERV 0.00
- CMBM 78.90
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.